Denali Therapeutics shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Denali Therapeutics by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $641k | 39k | 16.51 |
| 2024-03-31 | $405k | 20k | 20.52 |
| 2023-12-31 | $491k | 23k | 21.46 |
| 2023-09-30 | $775k | 38k | 20.63 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors